Meridian Medica

01

Identity

Botanical Profile

Dipsacus fullonum L. — Root (dried; primary medicinal part); Leaf (traditional); Seed head (ecological/craft use). Native to Europe, North Africa, and western Asia; widely naturalized across North America as a roadside and field biennial; now common throughout temperate North America

Root: bitter, slightly acrid, pungent; dense, fibrous cross-section with distinctive central channel in older roots; strong earthy-bitter aroma when cut fresh. Dried root: dark tan-brown, hard, fibrous. Taste: intensely bitter with earthy, woody undertones. The bitterness is characteristic and becomes important as a diagnostic indicator — authentic teasel root should be noticeably bitter. Water extracted from the leaf axis ('Venus' basin') was traditionally used as an eye wash and cosmetic.

Species Integrity

Dipsacus fullonum (wild teasel) and Dipsacus sativus (Fuller's teasel, with hooked bracts) are closely related and used interchangeably medicinally. Both are naturalized in North America. Dipsacus asper (Asian teasel, Xu Duan in Chinese medicine) is a distinct species with a more extensively documented clinical record in Chinese herbal medicine, but D. fullonum shares key active compounds and is the primary Western species.

02

Compounds

Active Compound Profile

Iridoid glycosides (loganin, sweroside, sylvestroside, cantleyoside)

0.5–3% dry weight

Bitter tonic via bitter taste receptor (TAS2R) activation; anti-inflammatory via NF-κB and COX-2 inhibition; hepatoprotective; anti-cancer cytotoxicity in some cell lines; antimicrobial activity

Saikosaponins and triterpenoid saponins

Variable; present in root

Anti-inflammatory; immunomodulatory; liver protective; adaptogenic properties similar to other saponin-containing plants

Dipsacus saponins (astersaponins)

0.1–0.5%

Anti-osteoporotic activity (stimulates osteoblast proliferation, inhibits osteoclast differentiation); bone remodeling support

Alkaloids (including tryptamine derivatives)

Trace amounts

Antimicrobial; possible CNS modulating activity

Chlorogenic acid, caffeic acid, and polyphenols

0.5–1.5%

Antioxidant; anti-inflammatory; hepatoprotective; mild antimicrobial

Absorption

Tincture or decoction for iridoid glycoside extraction: Iridoid glycosides are water-soluble and ethanol-soluble; both decoction and tincture preparations effectively extract key active compounds; tincture provides greater consistency and shelf stability

03

Pathways

Mechanism of Action

★★★☆☆ Bitter Tonic / Digestive Stimulation Iridoid glycosides (loganin, sweroside) activate TAS2R bitter taste receptors in the GI tract; trigger cephalic phase digestive secretion including gastric acid, bile, and pancreatic enzyme release; improve nutrient absorption and digestive efficiency

★★★☆☆ NF-κB / Anti-Inflammatory Iridoid glycosides and polyphenols inhibit NF-κB nuclear translocation; reduce TNF-α, IL-6, and COX-2; loganin and sylvestroside show specific anti-inflammatory activity in multiple in vitro models

★★★☆☆ Bone Remodeling / Osteogenesis Dipsacus saponins (astersaponins) stimulate osteoblast differentiation and proliferation (Wnt/β-catenin signaling); inhibit osteoclast differentiation (RANKL signaling); documented in multiple controlled in vitro and animal studies

★★★☆☆ Antimicrobial / Anti-Spirochetal Iridoids and alkaloids in teasel root have documented antimicrobial activity; Stephen Buhner's research and clinical observations suggest anti-spirochetal activity against Borrelia burgdorferi (Lyme disease); mechanism proposed involves disruption of spirochetal quorum sensing and biofilm formation

★★★☆☆ Hepatoprotection Iridoid glycosides demonstrate hepatoprotective activity in animal models; protect against chemically-induced hepatocellular damage; reduce liver enzyme elevation; anti-inflammatory effect in hepatic tissue

04

Biomarkers

Documented Biomarker Effects

Biomarker	Direction	Target	Mechanism
hs-CRP	↓ Decrease	<1.0 mg/L	Iridoid glycoside NF-κB inhibition reduces systemic inflammatory cytokine production
Liver Enzymes (ALT, AST)	↓ Decrease (if elevated)	ALT <35 IU/L; AST <35 IU/L	Hepatoprotective iridoids protect hepatocytes from inflammatory and oxidative damage; relevant if concurrent liver stress from medications or infections
Bone Density (DEXA)	↑ Improve	T-score > -1.0 (within normal range)	Dipsacus saponin stimulation of osteoblastogenesis via Wnt/β-catenin; RANKL inhibition of osteoclast differentiation
Joint Pain (VAS or WOMAC)	↓ Decrease	Clinical improvement in joint pain scores	NF-κB-mediated reduction of synovial inflammation; prostaglandin pathway modulation by iridoids

05

Extraction

Extraction & Preparation

Tincture (1:5, 60% ethanol): Full iridoid glycoside extraction; saponins and polyphenols included

Solubility · Water-soluble as glycosides; also ethanol-solubleMenstruum · 60% ethanolPlant material · Dried Dipsacus fullonum root, cut or powderedMaceration time · 4–6 weeks (agitate daily)Ratio · 1:5 (dried)

06

Biomarker Intel

Biomarker Intelligence

This herb has documented effects on the following markers:

Marker	Direction	Evidence	Notes
hs-CRP	↓ Decrease	traditional	Iridoid glycoside NF-κB inhibition reduces systemic inflammatory cytokine production
Liver Enzymes (ALT, AST)	↓ Decrease (if elevated)	traditional	Hepatoprotective iridoids protect hepatocytes from inflammatory and oxidative damage; relevant if concurrent liver stress from medications or infections
Bone Density (DEXA)	↑ Improve	traditional	Dipsacus saponin stimulation of osteoblastogenesis via Wnt/β-catenin; RANKL inhibition of osteoclast differentiation
Joint Pain (VAS or WOMAC)	↓ Decrease	traditional	NF-κB-mediated reduction of synovial inflammation; prostaglandin pathway modulation by iridoids

07

Dosing

Dosing Framework

Anti-inflammatory/Lyme protocol: take 3 doses spread throughout the day; with meals to reduce any GI discomfort from bitter compounds; morning, midday, evening timing.

Dose 1

Therapeutic (anti-inflammatory, Lyme protocol): 3–5 mL tincture, 3x daily

Buhner protocol dose; 4–6 month minimum duration for Lyme applications; monitor response

Dose 2

Bone support (TCM tradition): 10–15g dried root decoction daily

Follows D. asper (Xu Duan) TCM dosing tradition; decoction preferred for bone applications

Dose 3

Digestive bitters: 10–20 drops tincture, 10–15 minutes pre-meal

Sub-therapeutic anti-inflammatory dose; purely bitter tonic application; combine with other bitters (gentian, dandelion) for full formula

08

Synergies

Synergy Partners

★★★☆☆ Japanese Knotweed (Polygonum cuspidatum / resveratrol) Core Buhner Lyme protocol combination; knotweed's resveratrol provides NF-κB inhibition, SIRT1 activation, and potential anti-spirochetal activity via different mechanisms than teasel's iridoids; combined provides broader anti-inflammatory and anti-microbial coverage

★★★☆☆ Cat's Claw (Uncaria tomentosa) Oxindole alkaloids in cat's claw modulate T-cell and NK cell activity; immunomodulatory complementary to teasel's anti-inflammatory iridoids; combined addresses both immune dysfunction and inflammation in Lyme-Hashimoto's overlap

★★★☆☆ Boswellia (Boswellia serrata) AKBA (Boswellic acid) specifically inhibits 5-LOX and leukotriene B4 synthesis; teasel's iridoids inhibit COX-2 and NF-κB; combined covers both leukotriene and prostaglandin inflammatory pathways comprehensively

★★★☆☆ Gentian (Gentiana lutea) Gentian's secoiridoid bitters (gentiopicroside) are more potent bitter taste receptor activators than teasel's iridoids; combined digestive bitters formula provides more complete bitter tonic effect

Signature Stack

THE LYME-HASHIMOTO OVERLAP PROTOCOL
Components: Teasel Root (Dipsacus fullonum) + Japanese Knotweed (Polygonum cuspidatum) + Cat's Claw (Uncaria tomentosa) + Astragalus (Astragalus membranaceus) · Multi-pathway convergence: Anti-spirochetal / antimicrobial (teasel + knotweed + cat's claw) + NF-κB inhibition (knotweed resveratrol + teasel iridoids) + immune normalization (cat's claw + astragalus) + HPA adaptogenic support (astragalus) · Borrelia burgdorferi infection is documented as a significant trigger and perpetuator of autoimmune thyroid disease, including Hashimoto's. This stack addresses the Lyme-Hashimoto overlap that is clinically common but rarely recognized in conventional medicine. The herbs address both the potential microbial trigger and the resulting autoimmune inflammatory response. · Practical integration: Joint Support Tincture Blend (teasel + knotweed + cat's claw) taken 3x daily; astragalus decoction or tincture separately in morning protocol; work with a Lyme-literate integrative practitioner to determine if Lyme testing and protocol is indicated.

09

Safety

Contraindications & Interactions

Avoid Pregnancy Iridoid glycosides from teasel have theoretical uterotonic activity at high doses; traditional emmenagogue use of related Dipsacaceae plants documented. Insufficient safety data for pregnancy.

Minor Hypoglycemia / antidiabetic medications Iridoids from Dipsacus species have hypoglycemic activity in animal models; may potentiate insulin and antidiabetic medication effects.

Minor Bitter intolerance / GI sensitivity Therapeutic doses of iridoid-rich teasel root may cause nausea, GI cramping, or diarrhea in bitter-sensitive individuals.

11

Evidence

Evidence Base

★★★☆☆ Anti-Inflammatory (Iridoid Mechanism) Moderate — Strong mechanistic + in vitro/animal evidence; limited human RCTs

★★★☆☆ Bone Healing / Anti-Osteoporotic (D. asper / Xu Duan) Moderate — Multiple controlled animal studies + small human trials; primarily D. asper research

★☆☆☆☆ Anti-Spirochetal / Lyme Disease Support Preliminary — Clinical observation and theoretical; no controlled human RCT

★★★☆☆ Digestive Bitter Tonic Moderate — Mechanism well-established for iridoid bitters class; extensive traditional use

★★☆☆☆ Hepatoprotection Preliminary — Animal model evidence; limited human data

Evidence Gaps

A controlled pilot study evaluating teasel root tincture in Hashimoto's patients with confirmed or suspected Borrelia co-infection (measuring TPO antibodies, inflammatory markers, and Borrelia serology) would be a unique contribution to both integrative Lyme medicine and autoimmune thyroid disease management. Additionally, direct in vitro anti-Borrelia testing of D. fullonum specifically (rather than generic antimicrobial claims) would strengthen or refute the Buhner protocol scientific basis.

Quality Alert

Teasel root adulteration risk has increased with the Lyme disease herbal protocol market:

12

Protocol

Preparation Integration

Recipe Integration

Joint Support Tincture Blend (signature preparation)

3–5 mL, 3x daily with meals